Jinan Liangfu Jinghe Pharmaceutical Technology Co., Ltd.
MAILBOX | CHINESE | ENGLISH
R&D Center
Drug Discovery
New Drugs
· Anti-Cancer Drugs
· Cardiovascular System Drugs
· Anti-diabetic Drugs
· Anti-virus Drugs
· Antiepileptic Drugs
· Anti-depression Drugs
· Others
Intellectual Properties
Research Projects
Contact Us
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621
Fax: +86-531-88817925
Zip Code: 250101
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com
Medicine project Now Position:Home > R&D Center > > Medicine project < Others
spironolactone tablets
1, edema disease combined with other diuretics, treatment of congestive edema, cirrhosis ascites, renal edema and other edematous diseases, the purpose is to correct the above-mentioned diseases associated with increased secondary aldosterone secretion, and against other diuretics The role of potassium. Also used for the treatment of idiopathic edema.


2, high blood pressure as an auxiliary drug for the treatment of hypertension.


3, primary aldosteronism spironolactone can be used for the diagnosis and treatment of this disease.


4. Prevention of hypokalemia Combined with thiazide diuretics, it enhances diuretic effect and prevents hypokalemia.




Close
QQ1: 1762738062
QQ2: 1919147143
MSN: sales-trio
SKYPE: janisa.yan